Sensitivity and specificity analysis found that ABCG2 expression could be a good discriminator between cancerous and adjacent noncancerous tissues in both colon and rectum adenocarcinomas, and it may hence be potentially useful as a colorectal cancer biomarker. This evidence concerns the gene ABCG2 and digestive system cancer.